ウイルス性肝炎/レトロウイルス検査の世界市場2015-2019...市場調査レポートについてご紹介

【英文タイトル】Global Viral Hepatitis and Retrovirus Diagnostic Tests Market 2015-2019

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

PART 01: Executive summary
Highlights

PART 02: Scope of the report
Market overview
Top-vendor offerings

PART 03: Market research methodology
Research methodology
Economic indicators

PART 04: Introduction
Key market highlights

PART 05: Overview
Hepatitis
HIV

PART 06: Market landscape
Market overview
Market size and forecast
Five forces analysis

PART 07: Geographical segmentation
Global viral hepatitis and retrovirus diagnostic tests market by geographical segmentation
Viral hepatitis and retrovirus diagnostic tests market in Americas
Viral hepatitis and retrovirus diagnostic tests market in EMEA
Viral hepatitis and retrovirus diagnostic tests market in APAC

PART 08: Key focus countries
Brazil
China

PART 09: Market drivers

PART 10: Impact of drivers

PART 11: Market challenges

PART 12: Impact of drivers and challenges

PART 13: Market trends

PART 14: Vendor landscape
Competitive scenario
Market share analysis 2014
Other prominent vendors

PART 15: Key vendor analysis
Abbott Diagnostics
Alere
Chembio
DiaSorin
Roche Diagnostics

PART 16: Appendix
List of abbreviations

PART 17: Explore Technavio

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Global endemicity of hepatitis A infection
Exhibit 03: Endemicity pattern of hepatitis B across different regions
Exhibit 04: Prevalence rates of hepatitis B in APAC
Exhibit 05: Acute hepatitis B infection by age groups (2005-2013)
Exhibit 06: Chronic hepatitis B infection by age groups (2005-2013)
Exhibit 07: Prevalence of hepatitis B in US (2005-2013)
Exhibit 08: Prevalence rates of hepatitis C across different geographies (2012)
Exhibit 09: Prevalence data of hepatitis C in APAC
Exhibit 10: Prevalence data of hepatitis C in Europe
Exhibit 11: Prevalence data of hepatitis C in Caribbean and Latin America
Exhibit 12: Prevalence data of hepatitis C in Middle-East and North Africa
Exhibit 13: Prevalence data of hepatitis C in North America
Exhibit 14: Prevalence data of hepatitis C in Sub-Saharan Africa
Exhibit 15: Medical cost for chronic viral hepatitis
Exhibit 16: Medical cost for treatment of hepatitis C-related infections
Exhibit 17: Demographic statistics for HIV (2014)
Exhibit 18: Low-cost portable tests for HIV diagnosis
Exhibit 19: Top 10 countries with highest number of healthcare facilities providing HIV testing in 2013
Exhibit 20: Global viral hepatitis and retrovirus diagnostic tests market
Exhibit 21: Global viral hepatitis and retrovirus diagnostic tests market 2014-2019 ($ millions)
Exhibit 22: Five forces analysis
Exhibit 23: Segmentation of global viral hepatitis and retrovirus diagnostic tests market by geography 2014
Exhibit 24: Segmentation of global viral hepatitis and retrovirus diagnostic tests market by geography 2019
Exhibit 25: Segmentation of global viral hepatitis and retrovirus diagnostic tests market by geography 2014-2019
Exhibit 26: Viral hepatitis and retrovirus diagnostic tests market in Americas 2014-2019 ($ millions)
Exhibit 27: Viral hepatitis and retrovirus diagnostic tests market in EMEA 2014-2019 ($ millions)
Exhibit 28: Top countries in APAC with highest number of HIV patients (2012)
Exhibit 29: Viral hepatitis and retrovirus diagnostic tests market in APAC 2014-2019 ($ millions)
Exhibit 30: Viral hepatitis and retrovirus diagnostic tests market in Brazil 2014-2019 ($ millions)
Exhibit 31: Viral hepatitis and retrovirus diagnostic tests market in China 2014-2019 ($ millions)
Exhibit 32: Impact of drivers
Exhibit 33: Impact of drivers and challenges
Exhibit 34: Abbott Diagnostics: Key takeaways
Exhibit 35: Alere: Key takeaways
Exhibit 36: Chembio: Key takeaways
Exhibit 37: DiaSorin: Key takeaways
Exhibit 38: Roche Diagnostics: Key takeaways
Exhibit 39: Abbott Diagnostics: Key business offerings
Exhibit 40: Alere: Business segmentation by revenue 2014
Exhibit 41: Alere: Business segmentation by revenue 2013 and 2014 ($ millions)
Exhibit 42: Alere: Geographical segmentation comparison by revenue 2013 and 2014 ($ millions)
Exhibit 43: Chembio: Business segmentation by revenue 2014
Exhibit 44: Chembio: Business segmentation by revenue 2013 and 2014 ($ millions)
Exhibit 45: Chembio: Geographical segmentation by revenue 2014
Exhibit 46: DiaSorin: Business segmentation by revenue 2013 and 2014
Exhibit 47: DiaSorin: Geographical segmentation by revenue 2014


【レポート販売概要】

■ タイトル:ウイルス性肝炎/レトロウイルス検査の世界市場2015-2019
■ 英文:Global Viral Hepatitis and Retrovirus Diagnostic Tests Market 2015-2019
■ 発行日:2015年10月21日
■ 調査会社:Technavio
■ 商品コード:IRTNTR7415
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。